FOXP3 and cancer: Also, CD25 lost within activated T cells might be induced by competition for IL-2 between activated and regulatory T cells expressing higher levels of Foxp3, which has been directly associated with their potential to suppress the activation of effector T cells and correlated with cancer progression (29, 30).